Bank Of America Corp Regeneron Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

$1.06 Trillion
Q1 2024

A detailed history of Bank Of America Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 884,068 shares of REGN stock, worth $930 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

884,068

Previous 878,413 0.64%

Holding current value

$930 Million

Previous $772 Million 10.29%

% of portfolio

0.08%

Previous 0.08%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $5.1 Million - $5.62 Million	5,655 Added 0.64%	884,068 $851 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $30.9 Million - $35.2 Million	39,868 Added 4.75%	878,413 $772 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $76.2 Million - $90.4 Million	-108,865 Reduced 11.49%	838,545 $603 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $36.6 Million - $44.4 Million	53,728 Added 6.01%	947,410 $778 Million
Q4 2022 Feb 10, 2023	SELL	$705.89 - $766.39 $109 Million - $119 Million	-154,802 Reduced 14.76%	893,682 $645 Million

Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $7.93 Million - $10 Million	-13,820 Reduced 1.3%	1,048,484 $722 Million
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $47.7 Million - $64.2 Million	-86,940 Reduced 7.56%	1,062,304 $628 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $7.18 Million - $8.43 Million	-12,070 Reduced 1.04%	1,149,244 $803 Million
Q4 2021 Feb 08, 2022	BUY	$543.48 - $670.97 $2.74 Million - $3.38 Million	5,040 Added 0.44%	1,161,314 $733 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $23.2 Million - $27.5 Million	40,430 Added 3.62%	1,156,274 $700 Million
Q2 2021 Sep 13, 2021	BUY	$472.8 - $558.54 $528 Million - $623 Million	1,115,844 New	1,115,844 $623 Million

Others Institutions Holding REGN

# of Institutions

1,427

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Regeneron Pharmaceuticals, Inc. Transaction History